CNR Institutional Research Information System

ZECCA, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.812
NA - Nord America 1.251
SA - Sud America 526
EU - Europa 457
AF - Africa 42
OC - Oceania 3
Totale 5.091
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.192
SG - Singapore 1.173
CN - Cina 681
BR - Brasile 424
VN - Vietnam 335
HK - Hong Kong 262
FR - Francia 184
KR - Corea 123
IN - India 72
IT - Italia 57
DE - Germania 46
JP - Giappone 43
AR - Argentina 38
GB - Regno Unito 32
FI - Finlandia 29
CA - Canada 26
BD - Bangladesh 19
MX - Messico 19
NL - Olanda 18
ID - Indonesia 16
EC - Ecuador 15
IL - Israele 14
CO - Colombia 13
ES - Italia 12
RU - Federazione Russa 12
ZA - Sudafrica 12
IQ - Iraq 10
PY - Paraguay 9
UA - Ucraina 9
VE - Venezuela 9
MA - Marocco 7
PE - Perù 7
SA - Arabia Saudita 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
KE - Kenya 6
TR - Turchia 6
CZ - Repubblica Ceca 5
JO - Giordania 5
MY - Malesia 5
PA - Panama 5
PL - Polonia 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
AT - Austria 4
CL - Cile 4
IE - Irlanda 4
PT - Portogallo 4
RS - Serbia 4
SE - Svezia 4
TN - Tunisia 4
AL - Albania 3
NP - Nepal 3
PH - Filippine 3
PK - Pakistan 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
BE - Belgio 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
LT - Lituania 2
NZ - Nuova Zelanda 2
RO - Romania 2
TH - Thailandia 2
TW - Taiwan 2
YT - Mayotte 2
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BY - Bielorussia 1
DJ - Gibuti 1
DZ - Algeria 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
MT - Malta 1
NA - Namibia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
QA - Qatar 1
SI - Slovenia 1
TG - Togo 1
TZ - Tanzania 1
Totale 5.091
Salva come PNG Salva come JPEG
Città #
Singapore 684
Santa Clara 454
Hefei 311
Hong Kong 256
San Jose 183
Lauterbourg 127
Ho Chi Minh City 125
Seoul 122
Beijing 117
Ashburn 89
Hanoi 76
Los Angeles 38
Dallas 34
São Paulo 34
Frankfurt am Main 24
New York 24
Tokyo 24
Guangzhou 21
Helsinki 20
Mumbai 18
Rio de Janeiro 15
Bengaluru 14
Minamishinagawa 14
Buffalo 13
Biên Hòa 11
Da Nang 11
Belo Horizonte 10
Milan 10
Brooklyn 9
Atlanta 8
Boston 8
Brasília 8
Orem 8
Porto Alegre 8
Portsmouth 8
Chennai 7
Curitiba 7
Düsseldorf 7
Guayaquil 7
Haiphong 7
Johannesburg 7
Madrid 7
Quận Bình Thạnh 7
Turku 7
Baku 6
Chicago 6
Guarulhos 6
Manaus 6
Nairobi 6
Ribeirão Preto 6
São Gonçalo 6
Taiyuan 6
Amman 5
Brescia 5
Can Tho 5
Dhaka 5
Duque de Caxias 5
Nuremberg 5
Salvador 5
Arese 4
Asunción 4
Birmingham 4
Buenos Aires 4
Campinas 4
Dublin 4
Formosa 4
Goiânia 4
Hải Dương 4
Kolkata 4
Lima 4
Manchester 4
Montevideo 4
Nova Iguaçu 4
Phoenix 4
Queens 4
Baghdad 3
Bandung 3
Bexley 3
Bogotá 3
Bình Dương 3
Bắc Giang 3
Calgary 3
Charlotte 3
Denver 3
Elk Grove Village 3
Erbil 3
Falkenstein 3
Fortaleza 3
Hyderabad 3
Ipatinga 3
Irving 3
Kuala Lumpur 3
La Paz 3
Maceió 3
Marseille 3
Marília 3
Milwaukee 3
Monza 3
Munich 3
Nijmegen 3
Totale 3.221
Salva come PNG Salva come JPEG
Nome #
Engineered nanoparticles. How brain friendly is this new guest? 104
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals 89
Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease. 82
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease 82
Overexpression of Vesicular Monoamine Transporter-2 may Block Neurotoxic Metabolites from Cytosolic Dopamine: a Potential Neuroprotective Therapy for Parkinson's Disease 82
COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside 78
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease 75
Aluminium in Alzheimer's disease: are we still at a crossroad? 71
Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders 70
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells 68
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease 65
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease 63
Neuromelanins in brain aging and Parkinson's disease: synthesis, structure, neuroinflammatory, and neurodegenerative role 61
The neurobiology of human aggressive behavior: Neuroimaging, genetic, and neurochemical aspects 60
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 59
The role of neuromelanins in the oxidative stress of Parkinson's disease. 58
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain 58
Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour 57
The role of tyrosine hydroxylase as a key player in neuromelanin synthesis and the association of neuromelanin with Parkinson's disease 57
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models 56
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease 55
Convenient Synthetic Method Of Putative Degradative Markers To Identify Various Catecholic Metabolites In Addition To Dopamine And Norepinephrine Incorporated In Neuromelanin. 53
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease 52
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells 52
Neuromelanin a chelator of iron and other metals in catecholaminergic neurons of substantia nigra and locus coeruleus. 51
Neuromelanin of the Human Substantia Nigra: An Update 51
Water-Soluble Melanin-Protein-Fe/Cu Conjugates Derived from Norepinephrine as Reliable Models for Neuromelanin of Human Brain Locus Coeruleus 51
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease 49
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases 48
The protective and toxic role of neuromelanins in brain aging and Parkinson's disease 47
Neuromelanins Isolated from Different Regions of the Human Brain Exhibit a Common Surface Photoionization Threshold 47
Brain iron pathways and their relevance to Parkinson's disease. 46
Contrast mechanisms associated with neuromelanin-MRI 46
Synthetic models of neuromelanin with fibrillated protein in the core 45
Neuromelanin organelle pathways in aging and neurodegeneration of Parkinson's Disease 45
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease 44
IRON, COPPER AND THEIR MOLECULES IN SUBSTANTIA NIGRA OF NORMAL SUBJECTS DURING AGING 43
The role of neuromelanin organelle pathways in parkinson's disease 43
Melanic Pigments in the Human brain 43
Iron, Myelin, and the Brain: Neuroimaging Meets Neurobiology 43
NEUROMELANINS ACCUMULATE IN NEURONS DURING HUMAN BRAIN AGING AND BIND METALS 41
Neuromelanin organelles pathways in brain aging and Parkinson's disease 41
Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids. 41
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability. 41
The Role of Iron in Neurodegeneration 40
Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI 40
The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface. 40
Proteomic profile of neuromelanin and neuromelanin-containing organelles 40
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease 39
Protective and toxic role of neuromelanin in brain aging and Parkinson's disease 38
Neuromelanin activates microglia and induces substantia nigra neuron death. A key mechanism of Parkinson's disease. 38
Protective and toxic roles of dopamine in Parkinson's disease 38
The structure of neuromelanin as studied by chemical degradative methods 37
Neuromelanins in brain aging and Parkinson's disease. 37
Protective and neurotoxic role of neuromelanin in human brain 37
Oleh Hornykiewicz, a giant in the understanding and treatment of Parkinson disease. 36
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 36
NEUROMELANIN ORGANELLES AND AUTOPHAGY IN BRAIN AGING 36
Application of Pump-Probe Imaging Towards Chemical and Structural Characterization of Neuromelanin. 35
The Neuromelanin of Human Substantia Nigra: Physiological and Pathogenic Aspects 35
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. 35
Iron, brain ageing and neurodegenerative disorders. 34
Molecular understanding of aluminum bioinorganic chemistry in relevance to the pathology of Alzheimer's disease 34
Modeling Midbrain and Brainstem Neuromelanins to Characterize Metal Binding and Associated MRI Contrast in Parkinson's and Alzheimer's Diseases 34
The neuromelanin of human substantia nigra and its interaction with metals 33
NEUROMELANIN ORGANELLES PATHWAYS AND NEURODEGENERATION IN PARKINSON'S DISEASE 33
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry 33
Combined biochemical separation and INAA for the determination of iron and other metals in Neuromelanin of human brain Substantia Nigra 32
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease 32
Melanin-protein fibrils conjugates as models to study neuromelanin structure and reactivity. 32
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease 31
α-Synuclein and Dopamine Metabolites DOPAL and DOPAC: A Pathway to New Synthetic Neuromelanin Models 31
Amyloid beta and neuromelanin - Toxic or protective molecules? The cellular context makes the difference. 30
Neuromelanin-sensitive MRI as a proxy-measure of dopamine function in neuropsychiatric illness. 29
Neuromelanins, oxidative stress and Parkinson's disease 28
Neuromelanin and metals in brain aging and neurodegeneration. 28
Tracemetals, neuromelanin and neurodegeneration: An interesting area for research. 28
Iron, copper and their proteins in substantia nigra of human brain during aging. 28
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes. 27
The role of neuromelanin in brain aging and neurodegeneration of Parkinson's disease 27
The application of the Neutron Activation Analysis for trace metals determination in human brain tissues and substantia nigra neuromelanin. 27
NEURONAL MHC-I DISPLAY IN T-CELL MEDIATED NEURODEGENERATION 27
Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis. 27
Neuromelanin and metals in brain aging and neurodegeneration. 27
In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage 26
Biosynthetic pathway to neuromelanin and its aging process 26
Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus 26
Neuromelanin in human brain: protective and toxic role. 26
The role of neuromelanin and iron in brain aging and Parkinson's disease. 26
The relevance of low iron, high ferritin and high neuromelanin to neuronal vulnerability in parkinsonian syndromes. 25
The structure, synthesis and role of neuromelanins in brain aging and neurodegeneration 25
A modern imaging investigation of neuromelanin extracted from the substantia nigra region of the human brain. 24
Chemistry and biophysics of melanins 24
Effect on neurotransmitters and receptors in rat exposed to 50Hz electric and magnetic fields from conception to adult life 24
Low iron, high ferritin and high neuromelanin in locus coeruleus neurons. A biochemical profile with relevance to neuronal vulnerability in parkinsonian syndromes 24
Activation of microglia by neuromelanin: correlation of neuromelanin phagocytosis and degradation, reactive oxygen species production, and ventral midbrain neuron death. 24
The role of neuromelanin in brain aging and Parkinson's disease. 24
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration 24
Neuromelanin in the human brain: protective and toxic role. 24
Neuromelanin activates microglia and induces substantia nigra neuron death. 24
Totale 4.238
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.099
article - articoli 10.264
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 259
Totale 27.622
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202446 0 0 0 0 0 0 0 0 1 0 44 1
2024/20251.948 3 9 167 71 432 47 23 139 53 65 484 455
2025/20263.169 185 426 287 482 590 136 467 171 147 182 96 0
Totale 5.163